Format

Send to

Choose Destination
Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L825-L833. doi: 10.1152/ajplung.00206.2017. Epub 2017 Aug 10.

Benefits of oxytocin administration in obstructive sleep apnea.

Author information

1
Department of Medicine, The George Washington University, Washington, District of Columbia.
2
Department of Biomedical Engineering, The George Washington University, Washington, District of Columbia.
3
Laboratory of Cardiorespiratory Control, Department of Physiology, Pontificia Universidad Católica de Chile, Santiago, Chile; and.
4
Department of Pharmacology and Physiology, The George Washington University, Washington, District of Columbia dmendel@gwu.edu.

Abstract

Activation of oxytocin receptors has shown benefits in animal models of obstructive sleep apnea (OSA). We tested if nocturnal oxytocin administration could have beneficial effects in OSA patients. Eight patients diagnosed with OSA were administered intranasal oxytocin (40 IU). Changes in cardiorespiratory events during sleep, including apnea and hypopnea durations and frequency, risk of event-associated arousals, and heart rate variability, were assessed. Oxytocin significantly increased indexes of parasympathetic activity, including heart rate variability, total sleep time, and the postpolysommogram sleep assessment score, an index of self-reported sleep satisfaction. Although the apnea-hypopnea index was not significantly changed with oxytocin administration, when apnea and hypopnea events were compared independently, the frequency of hypopneas, but not apneas, was significantly (P ≤ 0.005) decreased with oxytocin treatment. Both apneas and hypopneas were significantly shortened in duration with oxytocin treatment. Oxytocin treatment significantly decreased the percent of apnea and hypopnea events that were accompanied with an arousal. Oxytocin administration has the potential to restore cardiorespiratory homeostasis and reduce some clinically important (objective and patient-reported) adverse events that occur with OSA. Additional studies are needed to further understand the mechanisms by which oxytocin promotes these changes in cardiorespiratory and autonomic function in OSA patients.

KEYWORDS:

obstructive sleep apnea; oxytocin; parasympathetic

PMID:
28798255
DOI:
10.1152/ajplung.00206.2017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center